Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debattama R Sen

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|October 30, 2016
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockadeKristen E Pauken, Morgan A Sammons, Pamela M Odorizzi, et al.
Nature Immunology|July 27, 2021
Epigenetic scars of CD8<sup>+</sup> T cell exhaustion persist after cure of chronic infection in humansKathleen B Yates, Pierre Tonnerre, Genevieve E Martin, et al.
Science (New York, N.Y.)|October 30, 2016
The epigenetic landscape of T cell exhaustionDebattama R Sen, James Kaminski, R Anthony Barnitz, et al.
Science (New York, N.Y.)|October 12, 2019
Migratory DCs activate TGF-β to precondition naïve CD8<sup>+</sup> T cells for tissue-resident memory fateVinidhra Mani, Shannon K Bromley, Tarmo Äijö, et al.
Biorxiv : the Preprint Server for Biology|January 28, 2026
CRISPR screens identify targets to rescue age-related T cell dysfunction in cancerAlex C Y Chen, Keely Y Ji, Cansu Yerinde, et al.
Nature Immunology|October 23, 2019
Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodelingFlavian D Brown, Debattama R Sen, Martin W LaFleur, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapyMatthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
Cancer Discovery|January 14, 2026
Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody TarlatamabAvanish Mishra, Catherine B Meador, Kruthika Kikkeri, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|October 30, 2016
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockadeKristen E Pauken, Morgan A Sammons, Pamela M Odorizzi, et al.
Nature Immunology|July 27, 2021
Epigenetic scars of CD8<sup>+</sup> T cell exhaustion persist after cure of chronic infection in humansKathleen B Yates, Pierre Tonnerre, Genevieve E Martin, et al.
Science (New York, N.Y.)|October 30, 2016
The epigenetic landscape of T cell exhaustionDebattama R Sen, James Kaminski, R Anthony Barnitz, et al.
Science (New York, N.Y.)|October 12, 2019
Migratory DCs activate TGF-β to precondition naïve CD8<sup>+</sup> T cells for tissue-resident memory fateVinidhra Mani, Shannon K Bromley, Tarmo Äijö, et al.
Biorxiv : the Preprint Server for Biology|January 28, 2026
CRISPR screens identify targets to rescue age-related T cell dysfunction in cancerAlex C Y Chen, Keely Y Ji, Cansu Yerinde, et al.
Nature Immunology|October 23, 2019
Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodelingFlavian D Brown, Debattama R Sen, Martin W LaFleur, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapyMatthew P Zimmerman, Amy C Huang, Emily K Cox, et al.
Cancer Discovery|January 14, 2026
Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody TarlatamabAvanish Mishra, Catherine B Meador, Kruthika Kikkeri, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8<sup>+</sup> T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Pageof 3